Public list: BIO 2016 (619) Pharma Startups (6570)
InCarda Therapeutics is a privately-held, clinical-stage biopharmaceutical company developing an approach of treating cardiovascular conditions by the inhalation route. The advantage of inhalation is that it delivers medicine in the “first pass” ...Show all
Company (Alive / Active)
Phone:
39899 Balentine Drive
Suite 185
Newark, 94560
California, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Novel method to slow ventricular rate | Mar 22, 2019 | Aug 18, 2020 | Patent |
Unit aerosol doses for anticoagulation | Jan 20, 2016 | Jun 02, 2020 | Patent |
Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation | Mar 22, 2018 | May 26, 2020 | Patent |
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration | May 10, 2018 | Oct 15, 2019 | Patent |
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration | Feb 26, 2015 | Aug 14, 2018 | Patent |